SCHEMBL19683785

SCHEMBL19683785

Nc1ncnc2c1c(-c1ccc(C(=O)N3CCCCC3)cc1)nn2-c1ccc(NC=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 6/20 0.46
▸ SRC P12931 3/20 0.46
▸ METTL3 Q86U44 1/20 0.42
▸ MTOR P42345 2/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ ITK Q08881 3/20 0.41
▸ PRKDC P78527 2/20 0.41
▸ PIK3CD O00329 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ HCK P08631 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ EPHB4 P54760 1/20 0.41
▸ PI4KB Q9UBF8 1/20 0.41
▸ BTK Q06187 3/20 0.40
▸ RET P07949 2/20 0.40
▸ LCK P06239 1/20 0.40
▸ CSF1R P07333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19683742 0.91 KIT (0.47) EGFRSRCMTORHDAC1ITK
SCHEMBL19683865 0.86 SRC (0.52) EGFRSRCMTORHDAC1PRKDC
SCHEMBL19683619 0.80 SRC (0.56) EGFRSRCMTORPRKDCPIK3CD
SCHEMBL19683700 0.79 FLT3 (0.48) EGFRSRCHDAC1ITKABL1
SCHEMBL19683784 0.78 FLT3 (0.68) BTKRETLCKCSF1RPDGFRB
SCHEMBL19683651 0.78 SRC (0.49) EGFRSRCMTORITKPRKDC
SCHEMBL19683638 0.77 SRC (0.49) EGFRSRCMTORHDAC1PRKDC
SCHEMBL20878976 0.76 SRC (0.49) EGFRSRCMTORPRKDCPIK3CD
SCHEMBL23047313 0.75 SRC (0.47) EGFRSRCMTORPRKDCPIK3CD
SCHEMBL20878948 0.74 SRC (0.55) EGFRSRCMTORHDAC1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017206962-A1 NOVEL INHIBITOR FOR FLT3 KINASE AND USES THEREOF 合肥中科普瑞昇生物医药科技有限公司 2017-12-07 — — WO disclosed
Send feedback